Amrize (NYSE:AMRZ) Stock Rating Upgraded by Barclays

Amrize (NYSE:AMRZ) was upgraded by investment analysts at Barclays to a “hold” rating in a report issued on Thursday, Zacks reports.

Several other research analysts also recently weighed in on the stock. Bank of America restated an “underperform” rating and issued a $40.00 target price (down from $50.00) on shares of Amrize in a research note on Wednesday, September 2nd. Stephens cut their price objective on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a report on Wednesday, August 12th. DA Davidson assumed coverage on shares of Amrize in a research report on Monday, August 24th. They issued a “neutral” rating and a $50.00 price objective for the company. Citigroup downgraded Amrize from a “buy” rating to a “cautious” rating in a research note on Wednesday, September 9th. Finally, William Blair set a $40.00 target price on Amrize in a research report on Wednesday, September 2nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $53.24.

Amrize Stock Performance

Shares of AMRZ stock opened at $37.24 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The firm has a market capitalization of $20.60 billion, a price-to-earnings ratio of 17.16, a price-to-earnings-growth ratio of 1.31 and a beta of 0.21. Amrize has a one year low of $36.55 and a one year high of $65.94. The company has a 50 day moving average price of $43.88 and a 200 day moving average price of $50.20.

Amrize (NYSE:AMRZ) last posted its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The business had revenue of $3.49 billion for the quarter. Sell-side analysts anticipate that Amrize will post 2.46 EPS for the current year.

Insider Activity at Amrize

In other news, insider Stephen Clark acquired 5,260 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were bought at an average price of $47.31 per share, with a total value of $248,850.60. Following the purchase, the insider owned 10,637 shares of the company’s stock, valued at approximately $503,236.47. This represents a 97.82% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jan Jenisch purchased 26,000 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was acquired at an average price of $42.47 per share, for a total transaction of $1,104,220.00. Following the transaction, the chief executive officer owned 1,767,000 shares of the company’s stock, valued at $75,044,490. The trade was a 1.49% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 48,983 shares of company stock worth $2,158,755 in the last ninety days. 0.54% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Amrize

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Barclays PLC boosted its holdings in Amrize by 95.4% in the 4th quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock valued at $249,557,000 after purchasing an additional 2,253,431 shares during the period. DJE Kapital AG increased its holdings in shares of Amrize by 2,005.4% during the 4th quarter. DJE Kapital AG now owns 762,887 shares of the company’s stock worth $41,986,000 after purchasing an additional 726,652 shares during the period. First Manhattan CO. LLC. raised its position in shares of Amrize by 20.0% during the fourth quarter. First Manhattan CO. LLC. now owns 4,036,704 shares of the company’s stock valued at $218,305,000 after buying an additional 672,030 shares during the last quarter. River Road Asset Management LLC raised its position in shares of Amrize by 26.1% during the fourth quarter. River Road Asset Management LLC now owns 2,883,536 shares of the company’s stock valued at $155,942,000 after buying an additional 597,542 shares during the last quarter. Finally, Amundi lifted its stake in shares of Amrize by 30.9% in the first quarter. Amundi now owns 1,654,739 shares of the company’s stock valued at $92,698,000 after buying an additional 390,750 shares during the period.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.